Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What Are Wall Street Analysts' Target Price for Edwards Lifesciences Stock?

Valued at a market cap of $45.7 billion, Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases. The Irvine, California-based company is known for its patient-centric approach and close collaboration with physicians. 

This healthcare company has underperformed the broader market over the past 52 weeks. Shares of EW have gained 10.9% over this time frame, while the broader S&P 500 Index ($SPX) has soared 14%. Moreover, on a YTD basis, the stock is down 7.7%, compared to SPX’s 1.3% return.

Fundamentals

See More
  • Market Capitalization, $K 45,675,408
  • Shares Outstanding, K 580,300
  • Annual Sales, $ 5,440 M
  • Annual Income, $ 4,175 M
  • EBIT $ 1,385 M
  • EBITDA $ 1,540 M
  • 60-Month Beta 0.94
  • Price/Sales 7.87
  • Price/Cash Flow 28.60
  • Price/Book 4.49

Options Overview Details

View History
  • Implied Volatility 38.08% (-1.77%)
  • Historical Volatility 20.43%
  • IV Percentile 90%
  • IV Rank 58.63%
  • IV High 52.16% on 04/08/25
  • IV Low 18.11% on 08/28/25
  • Expected Move (DTE 11) 4.53 (5.87%)
  • Put/Call Vol Ratio 11.01
  • Today's Volume 2,269
  • Volume Avg (30-Day) 1,930
  • Put/Call OI Ratio 2.07
  • Today's Open Interest 66,782
  • Open Int (30-Day) 67,835
  • Expected Range 72.62 to 81.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.62
  • Number of Estimates 13
  • High Estimate 0.64
  • Low Estimate 0.60
  • Prior Year 0.59
  • Growth Rate Est. (year over year) +5.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
76.91 +0.20%
on 02/09/26
86.19 -10.60%
on 01/22/26
-8.07 (-9.48%)
since 01/09/26
3-Month
76.91 +0.20%
on 02/09/26
87.89 -12.32%
on 12/05/25
-6.33 (-7.59%)
since 11/07/25
52-Week
65.94 +16.86%
on 04/09/25
87.89 -12.32%
on 12/05/25
+6.71 (+9.54%)
since 02/07/25

Most Recent Stories

More News
What Are Wall Street Analysts' Target Price for Edwards Lifesciences Stock?

While Edwards Lifesciences has underperformed the S&P 500 over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

EW : 76.85 (-2.36%)
$SPX : 6,976.64 (+0.64%)
UBS : 44.48 (+1.30%)
IHI : 58.14 (-0.38%)
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2025 after the market closes on Tuesday, February 10, and will host a conference call at 5:00...

EW : 76.85 (-2.36%)
Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 46 th Annual Health Care Conference on Monday, Mar. 2, 2026. Scott Ullem,...

EW : 76.85 (-2.36%)
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors

Healthcare stocks rebounded in 2025. These three healthcare growth stocks offer exposure to innovation beyond traditional biotech risk

EW : 76.85 (-2.36%)
JNJ : 238.88 (-0.46%)
ISRG : 492.85 (+0.96%)
IQV : 193.09 (+2.99%)
What to Expect From Edwards Lifesciences' Q4 2025 Earnings Report

Edwards Lifesciences is expected to announce its fiscal fourth-quarter earnings soon, and analysts project a single-digit earnings growth.

EW : 76.85 (-2.36%)
XLV : 156.61 (-0.70%)
$SPX : 6,976.64 (+0.64%)
Edwards Comments on JenaValve Acquisition

Edwards Lifesciences (NYSE: EW) today announced that the U.S. District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission (FTC) for an injunction blocking...

EW : 76.85 (-2.36%)
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

EW : 76.85 (-2.36%)
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy

Edwards Lifesciences (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach to receive U.S. Food and Drug...

EW : 76.85 (-2.36%)
Stocks Rebound on Strength in Chip Stocks and a Benign US CPI Report

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.79%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +1.43%. December E-mini S&P futures...

MSTR : 135.87 (+0.70%)
AMAT : 330.93 (+2.61%)
CNK : 25.77 (+0.43%)
SNDK : 595.34 (-0.44%)
GLXY : 21.20 (+7.29%)
MRK : 117.16 (-3.91%)
$IUXX : 25,319.01 (+0.97%)
COIN : 166.73 (+0.98%)
ASML : 1,432.69 (+1.39%)
DJT : 11.34 (-0.96%)
ZNH26 : 112-060 (+0.07%)
ESH26 : 6,995.75 (+0.62%)
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026. Bernard Zovighian, chief executive officer,...

EW : 76.85 (-2.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair...

See More

Key Turning Points

3rd Resistance Point 80.69
2nd Resistance Point 79.79
1st Resistance Point 79.25
Last Price 76.85
1st Support Level 77.81
2nd Support Level 76.90
3rd Support Level 76.36

See More

52-Week High 87.89
Fibonacci 61.8% 79.51
Fibonacci 50% 76.92
Last Price 76.85
Fibonacci 38.2% 74.32
52-Week Low 65.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar